Contract development and manufacturing organization Vetter initiated construction of a $285 million, 160,000-square-foot clinical manufacturing facility in Des Plaines, Illinois, aiming for full operation by 2029. The new site will augment aseptic production capabilities for innovative drug candidates, complementing Vetter's Austrian operations. Local government officials highlighted the project’s economic benefits and job creation. This expansion reflects growing demand for clinical-grade manufacturing capacity supporting early drug development stages in the biopharma sector.